Marco Di Maio retweeted
Figure depicting atypical ECG features of RBBB and LBBB that are suggestive of ventricular tachycardia @ECGTalk @adribaran @DrFerminGarcia @JonPicciniSr @rafavidalperez @LluisMont2 @DrJasonAndrade @EM_RESUS @SergioPinski @DoctorPhillEP @SABOURETCardio @EladAnter @iamritu #Heart
Marco Di Maio retweeted
Updated guidelines and expert consensus documents in Europe and the United States are now relatively aligned with respect to recommendations for antithrombotic therapy in patients with atrial fibrillation undergoing PCI.
authors.elsevier.com/a/1csDs…
Marco Di Maio retweeted
“It is difficult to be productive at the best of times, let alone during a global crisis. So if you feel like you are failing because you aren’t “productive enough”, stop lying to yourself.”
@kaleybrauer #research #postdocs
arxiv.org/abs/2103.16574?fbc…
Marco Di Maio retweeted
#TrickOrTweet For my fellow #cardiotwitter nerds 👻 @DrMarthaGulati @mmamas1973 @hvanspall @HeartOTXHeartMD @wordfinga @wayounihan @djc795 @iamritu @dmitripapa @BethFratesMD @DBelardoMD @willsuh76 @SVRaoMD @JGrapsa @mirvatalasnag @SABOURETCardio @AnastasiaSMihai @fischman_david – at Philadelphia, PA
Marco Di Maio retweeted
Treating with broad spectrum antibiotics without sending cultures first #stewardmeme teapawt.net/Laughs_4_All/status/13…
Marco Di Maio retweeted
Congratulations, @DFCapodanno! This is an important document for the field of #cardiology. Thanks for including me with this great group. @DLBHATTMD @CMichaelGibson @vlgmrc @mwkrucoff @Urphi @mc_morice @Drroxmehran @SVRaoMD #cardiotwitter #clinicaltrials
The second consensus document from the Academic Research Consortium for HBR on principles of trial design for patients at high bleeding risk undergoing PCI is now online in JACC.
onlinejacc.org/content/76/12…
@DLBHATTMD @CMichaelGibson @vlgmrc @mwkrucoff @Urphi @mc_morice @Drroxmehran
Marco Di Maio retweeted
Directly from the @escardio guidelines for atrial fibrillation, yet another flow chart on dual or triple therapy, which seems to say "do what you want, but do it with science and conscience" (and a bit of aspirin).
#ESCCongress
escardio.org/Guidelines/Clin…
Marco Di Maio retweeted
Seems like yet another meta-analysis of DAT vs TAT for PCI patients with AF... and probably it is, but ours is full optional and, more importantly, we had fun in doing it. @DLBHATTMD @CMichaelGibson @RenatoDLopes1 @Drroxmehran @marcodimaio88 @AGrecoMD
ahajournals.org/doi/10.1161/…
Marco Di Maio retweeted
Congratulations to @DFCapodanno on being newly appointed as Editor-in-Chief of EuroIntervention.
He succeeds the co-founder of the Journal, Patrick W. Serruys! (effective as of 1 January 2020) 👏👏
https://teapawt.net/t.co/YqzTz7eIJy
Marco Di Maio retweeted
Why P2Y12 inhibitors de-escalation could not be an optimal strategy in diabetic ACS patients. Reasons in one figure 😎
"De-escalation of oral P2Y12 inhibitors guided by platelet function testing in ACS patients undergoing PCI: impact of diabetes mellitus" by @PCapranzano and Dominick J. Angiolillo #EAPCI https://teapawt.net/t.co/VdZk7uRLtX @EuroInterventio @PCRonline @escardio #DAPT
Marco Di Maio retweeted
If you want to get bored reading a review on switching P2Y12 inhibitors and if you want some indications on how to do it 😎
authors.elsevier.com/a/1ZbqA…
Marco Di Maio retweeted
Calcified lesions? No problem! Check out this interventional tool list for #PCI of calcified coronary lesions in #JACCINT. fal.cn/33C2a
Marco Di Maio retweeted
#JACC State-of-the-Art Review: Learn the best approach for managing antithrombotic therapy in #AFib patients undergoing #PCI. fal.cn/32Ku8 @UFMedicineJax @DFCapodanno
Marco Di Maio retweeted
Before heading out of the cathlab for the summer holidays, join our next #EIJCardioChat! We'll discuss the #EAPCI consensus on the Clinical use of intracoronary imaging. Part 2 with @twj1974 @VijayKunadian and @jedicath to moderate the chat!
🗓️July 10th 5:00 PM Paris time
Marco Di Maio retweeted
I like it so much, I just had to share it
@AGIKinterv @DGK_org @PCRonline #cardiotwitter #cardiology @ESCardioNews
Marco Di Maio retweeted
The 2018 impact factors are out - see below for cardiac and cardiovascular systems:
@ESC_Journals leading by 0.185 IF, followed by
@CircAHA and
@JACCJournals
#Science #Cardiology #Cardiotwitter #ImpactFactor
Marco Di Maio retweeted
#TipsforNewDocs
Notes: specify treatment course by dates, not just duration.
Wrong: “2w of abx.”
Right: “2w of abx, last dose 7/4/19.”
Everyone who copies your note forward, or reads your note for actual useful information, will thank you!
#kittlesonrules #meded
Marco Di Maio retweeted
#TipsForNewDocs
Heart failure:
1) EF 20% —> 10% in the absence of new symptoms doesn’t mean much
2) Rising Cr: don’t assume the pt is dry- think about low cardiac index
3) HF pt needs metolazone, midodrine, or home oxygen: worrisome prognostic signs
#kittlesonrules #meded




































